BP-SCIG 20%

· Biopharma Plasma LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BP-SCIG 20%, covering 2026-01-16 to 2026-01-16. Get the full timeline:

Most recent: Clinical Trial Update: Study of BP-SCIG 20% in Patients With Primary Immunodeficiency (PID) [Phase 3]